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In this research project the liver specific progenitor cell (LPC) and its signalling pathways were studied in the dog, by the use of immunohistochemistry. LPC’s play an important role in the ability of the liver to regenerate in response to tissue damage. After activation, LPC’s proliferate (then called reactive ductules) and can differentiate into hepatocytes or cholangiocytes in order to restore the liver’s physiological functions. Much is still unknown about this activation and the signalling pathways involved in this process, making it an interesting subject for research.
In this research project we were particularly interested in the Notch and Wnt signalling pathways, since their involvement in the activation of human and rat LPC’s has recently been suggested [14][8].
Initially, immunohistochemistry was performed on paraffin-embedded liver tissue samples. Results showed that the use of paraffin-embedded liver tissue wasn’t satisfying, since outcome of many different staining protocols used varied from negative staining to such high background staining that no conclusions could be drawn from these stainings.


























In veterinary medicine, canine liver disease is a common phenomenon. Fortunately, the liver possesses an extra-ordinary way to respond to tissue damage; regeneration. Liver regeneration, having presumably evolved to protect animals in the wild from the catastrophic results of liver loss caused by food toxins, has been an object of curiosity for many years. The ancient Greeks recognized liver regeneration in the myth of Prometheus. Having stolen the secret of fire from the gods of Olympus, Prometheus was condemned to having a portion of his liver eaten daily by an eagle. His liver regenerated overnight, thus providing the eagle with eternal food and Prometheus with eternal torture [16]. 
However, liver regeneration cannot always be relied upon to take place after liver injury. In the event of ineffective or even total absence of liver regeneration, the life-threatening picture of liver failure may appear [4]. In other cases there may be incomplete liver regeneration, a condition known as hepatic fibrosis, in which the damaged liver tissue is replaced not by cells of the same kind, but by substitute tissue. This state of hepatic fibrosis tends to progress, ultimately leading to the destruction of the liver architecture, terminating in hepatic cirrhosis with the clinical picture of chronic liver failure, a condition with a notoriously bad prognosis [6].
Despite vigorous research efforts during the last few decades, the pathophysiology of liver regeneration is still largely unknown. In view of the growing importance of liver regeneration as the basis for treatment of many liver diseases, one of the objectives of current research is to achieve a better understanding of the extracellular and intracellular signals which govern liver regeneration, and thereby to develop new therapeutic strategies for stimulation of liver regeneration and prevention of liver fibrosis, in the hope of reducing the incidence and morbidity of hepatic cirrhosis.

Etiology of canine hepatitis
An infectious etiology is often suspected in canine hepatitis, but despite the existence of many known etiologic factors, the etiology of individual causes stays largely unknown [2].
Many infectious agents known for causing hepatitis have yet been identified; viruses (canine adenovirus/Rubarth virus), bacteria (Clostridium piliformis, Leptospira), protozoa (Toxoplasma gondii, Neospora, Leishmania) and fungi (Histoplasma capsulatum). Several toxic agents are also known for causing hepatitis; copper, blue green algae and therapeutic drugs such as trimetoprim sulfa, benzodiazepine and carprofen [6]. But as said, the etiology of individual causes stays largely unknown.

Histological changes in canine hepatitis
Hepatitis in veterinary hepatology always includes hepatocellular cell death; apoptosis and/or necrosis, and an inflammatory infiltrate varying in type and extend [12]. Furthermore, acute hepatitis (AH) sometimes features regeneration, whereas chronic hepatitis (CH) always conveys regeneration and fibrosis. Lobular dissecting hepatitis (LDH) is a special form of chronic hepatitis, in which the lobular architecture is completely disrupted by fine fibrotic septa [6].
Following hepatic inflammation, the liver gives rise to a tissue repair response in order to regain its physiological function. 
Liver tissue repair
This tissue repair respons (hepatocellular regeneration) can occur by two means;
A)	replication of mature hepatocytes and cholangiocytes and,
B)	in case of hampered hepatocytic reproduction, also by proliferation of the liver specific stem cell, the liver progenitor cell (LPC) [8].
























	Fig. 1; Differentiation pathways of the LPC [8]













Fig. 2; Cell lineages in the liver [5]
In adult livers, both hepatocytes and cholangiocytes can replicate. LPC’s form a bipotential reserve compartment capable of generating hepatocytes and cholangiocytes whenever regular replication is inadequate [5]. It is thought that cells surrounding the progenitor cells, amongst which the mesenchymal cells, release signals that regulate the activity of the progenitor cells. These surrounding cells with their signals and signal transduction pathways are called the progenitor cell niche.
These signal transduction pathways involved in adult progenitor cell activation have yet been described in other organs with a continuous cellular turnover, for example the intestines. The homeostatic self-renewal of the intestine depends on a complex interplay between processes involved in cell proliferation, differentiation, migration, adhesion and cell death. This cellular response is coordinated by a relatively small number of highly evolutionarily conserved signaling pathways, which include the Notch and Wnt signaling pathways [3].






Signal transduction pathways are efficient systems that allow cells to amplify faint signals in order to create intense, vital responses. A key element of virtually any signaling pathway is the interaction and regulation of various intracellular intermediates within the pathway.

















The Jagged family of transmembrane proteins are ligands for Notch receptors, which control the proliferation and/or differentiation of many cell lineages.















Fig. 4; Immunolocalization of Jagged-1 expression in normal and diseased adult human liver tissue. A;  In the parenchyma of normal liver tissue, Jagged-1 is localized to the cell membrane of hepatocytes (arrowheads) and the endothelium of the hepatic vein (arrow). B; Strong Jagged-1 immunoreactivity is associated with reactive bile ductules in PBC liver tissue (black arrows)  ADDIN EN.CITE [12]. 


The Wnt signalling pathway (Fig. 5)
The Wnt signalling pathway is highly conserved throughout animal development where it exerts pleiotropic effects on cell proliferation, differentiation and polarity or migration. The Wnt signalling pathway is identified as a signalling pathway that critically regulates various postnatal stem cell compartments, including the hematopoietic, skin and enteric systems. The central mediator of canonical Wnt signalling is ß-catenin, which acts as an activator of gene transcription by binding to the nuclear complex.
During liver development, ß-catenin was shown to critically regulate hepatic progenitor cell proliferation. It was even shown that over expression or inhibition of ß-catenin during development results in either an increase or a decrease in overall liver size, respectively [17].







































Summary of previous research
Previous study on these signalling pathways has been done by B.A. Schotanus et al., in which healthy liver tissue was compared to a specific type of chronic liver injury; lobular dissecting hepatitis (LDH), by use of laser-microdissection, gene expression studies (Q-PCR), and immunohistochemistry/-fluorescence.
Results showed an activated state of the Notch and Wnt pathways in the activated LPC (niches). The Wnt pathway seemed to be particularly involved in proliferation of the LPC, whereas the Notch pathway seemed to be particularly involved in LPC differentiation into biliary cells and seemed to function inhibitory on LPC differentiation into hepatocytes. 

Aim of the research project





















































Paraffin embedded tissue versus frozen tissue material
Immunohistochemistry can be carried out on paraffin-embeded liver tissue as well as on frozen liver tissue. Initially, the goal was to stain Notch1 and β-catenin in paraffin-embedded liver tissue. For this there are a couple of reasons which are listed below. 

Advantages of paraffin embedded material versus frozen material [10];	
-greater availability of paraffin-embedded, diseased liver tissue,
-better morphology of paraffin-embedded material,
-better resolution at higher magnifications,
-better cutting possibilities (less cutting-artifacts),




Disadvantages of paraffin embedded material versus frozen material [10];	
-fixation and embedding cause antigen masking. In order to overcome the 
drawback of antigen loss, enzymatic- or heat- mediated antigen retrieval has to be used,
-cryostat sections give much better antigen preservation than paraffin sections.
If immunohistochemical staining on paraffin-fixed liver tissue would prove unsatisfying there was also frozen liver tissue available to obtain data from.

Immunohistochemistry on paraffin-embedded liver tissue
Single immunostaining was performed on formalin fixed paraffin embedded tissue samples for Notch-1 (ab sc-6014 from Santa Cruz Biotechnology, rabbit polyclonal) and β-catenin (ab 2982 from Abcam, rabbit polyclonal).
To optimize staining results, different antigen retrievals, boiling times, H2O2 blocks, washes, serum blocks and antibody dilutions were tried for Notch-1 (see attachment A pa 24) as well as for β-catenin (see attachment B page 28). For the protocols used see attachment C on page 30 for Notch-1 and attachment D on page 31 for β-catenin.
Since outcome of the different optimization protocols was not satisfying, which is shown in earlier mentioned attachments, Notch-1 and β-catenin staining was repeated on frozen tissue samples.

Immunohistochemistry on frozen liver tissue
Frozen liver tissue of different types of liver diseases were stained for CK 7, Notch and β-catenin. CK 7 staining was performed mainly to determine localisation and the amount of progenitor cells present in the slides.
Cryosections (6 µm) were cut on a cryostat at -20°C. The collected slides were dried at room temperature for three hours and fixated in acetone for ten minutes and dried at air for ten minutes again. Sections were then stored in aluminum foil at – 70 and dried at air for 20 min. in aluminum foil and dried at air for 10 min. without aluminum foil before use. For CK7, brief washing steps were performed in PBS or PBS 0.1% Tween20. Endogenous peroxidise activity was blocked in RTU DAKO standard H2O2, background staining was blocked with normal goat serum (1:10 in PBS), antibody incubations (with Mouse anti CK7 1:50) occurred at RT for 30 min. and visualization was obtained by diaminobenzidine and counter stain consisted of a 10 sec. haematoxylin stain. Slides were covered with Vectamount. For the complete staining protocol see attachment E, page 32.
For Notch-1 and ß-catenin, brief washing steps were performed in TBS or TBS-0.025% Triton. Endogenous peroxidise activity was blocked in RTU DAKO standard H2O2, background staining was blocked with normal goat serum (1:10 in TBS), antibody incubations (1:50 for Notch-1 and 1:200 for ß-catenin in TBS-0.025% Triton) occurred overnight  and visualization was obtained by diaminobenzidine and counter stain consisted of a 10 sec. haematoxylin stain. Slides were covered with Vectamount. 










Liver tissue samples used




-primary portal vein hypoplasia		n=5
-extra hepatic bile duct obstruction	n=2
-negative control (liver tissue)		n=1
-positive control (intestine)		n=1
The number of tissue samples used per disease depended on the availability.
The healthy liver tissue samples used concerned surplus-liver tissue form dogs used in non-liver related experiments. 




































As mentioned in the materials and methods, different antigen retrievals, washings, blockings etc. were used in the staining protocol to optimize staining results for Notch-1 as well as for ß-catenin on paraffin-embedded liver tissue.


















Fig. 8; Staining result after using Citrate (pH 6.0) as antigen retrieval (boiled for 30 min. in a microwave), a 0.35% H202 block, PBS(T) as washing, 10% normal goat serum for serum blocking and a 





























































Fig. 11; Staining results after using a standard antigen unmasking solution as antigen retrieval (boiled for 3 min. in a microwave), a 0.35% H202 block, 0.025% T TBS as washing, 10% normal goat serum for serum blocking and a ß-catenin antibody dilution of 1:50. Results show that there is a lot of background staining but no specific staining.








































































































































Primary portal vein hypoplasia (PPVH)	







































Extra hepatic bile duct obstruction












































Negative control (liver tissue)














































Although many attempts were done to optimize staining results on paraffin-embedded liver tissue for Notch-1 as well as for β-catenin, unfortunately none of them proved satisfying enough to be able to draw conclusions out of the staining results. There are many possibilities for why staining results come out unsatisfying, of which a couple are listed below;

-The antibody may not be suitable for IHC procedures which reveal the protein in its native. This is not the case, since staining on frozen liver tissue showed that the antibody was suitable.
-The protein of interest is not abundantly present in the tissue. Staining on frozen liver tissue showed that this is not the reason because our antigen of interest was abundantly present.
-Fixation procedures (using formalin and paraformaldehyde fixatives) may be modifying the epitope the antibody recognizes.
-The secondary antibody may be binding non-specifically (damaged),
-Some antibodies only work on fresh, unfixed, frozen tissue,
- Because antigen-antibody reactions are reversible, the simple immune complexes formed on the tissue may dissociate during the washing cycles used in immunohistochemistry. The ease and degree of dissociation vary from antibody to antibody.
Unfortunately, time was short to continue optimizing staining results. Hopefully in the future the right staining protocol will be found so the advantages of the use of paraffin-embedded tissue can be exploited.

Frozen liver tissue
Liver regeneration is a very complex process influenced by a great variety of growth factors, cytokines, cell-cell interactions and the liver specific progenitor cell (LPC). In this study the involvement of the signalling pathways Notch and Wnt in the activation of LPC’s was investigated by the use of immunohistochemistry. In the past, research has already suggested that both Notch and Wnt play an important role in the activation of LPC’s in human and rat livers [1] [8].
Research done by Schotanus et al. [15] demonstrated the role of Wnt and Notch in proliferation and differentiation of the LPC’s during a specific type of liver disease in the dog; lobular dissecting hepatitis (LDH). LDH is a type of liver disease which is characterised by extended fibrosis throughout the liver tissue. In this severe state of liver tissue damage replication of mature hepatocytes isn’t sufficient to regain its physiological function. Therefore LPC’s replicate (their numbers increase) and differentiate into hepatocytes and cholangiocytes which was also observed in the CK 7 staining. Notch-1 and β-catenin were up regulated in the LDH tissue compared to healthy liver tissue, demonstrating the involvement of signalling pathways Notch-1 and Wnt in the activation of LPC’s in this type of liver disease. Moreover, it was suggested that Wnt was especially involved in proliferation of the LPC’s and their differentiation into hepatocytes, whereas Notch-1 was suggested to be especially involved in differentiation of the LPC’s into cholangiocytes [15].
This prompted us to study LPC’s and their signalling pathways in different types of liver disease as well and compare them to previously collected data.
In Healthy liver tissue small amounts of LPC’s were observed. These cells stained negative for Notch-1 and showed moderate membranous staining for β-catenin, showing that Notch-1 and Wnt aren’t activated in resting LPC’s. This suits results of previous research performed on healthy liver tissue of rats [1] [8].
In acute hepatitis, a disease which in general is mainly characterised by extensive inflammation, a few reactive ductules were seen, suggesting a minimal activation of LPC’s. This could indicate that the replication of mature hepatocytes and cholangiocytes, up to a certain level, is sufficient enough for liver regeneration. Since reactive ductules show increased membranous staining for β-catenin and no Notch-1 staining, this suggests that there is indeed proliferation of LPC’s and differentiation into hepatocytes, but no differentiation into cholangiocytes (yet). The one slide in which Notch-1 staining of reactive ductules was seen (Fig. 14A and B), indicates that in this case LPC’s did differentiate into cholangiocytes as well. As acute hepatitis becomes more chronic and tissue damage becomes more severe, proliferation and differentiation can increase, as can be seen in LDH and active cirrhosis. 
In active cirrhosis, liver injury is merely characterised by an extensive increase in fibrotic tissue and less inflammation. A large amount of reactive ductules were seen, showing that in this severe state of liver tissue damage replication of mature hepatocytes and cholangiocytes falls short and LPC’s come into play in order of liver regeneration. Notch-1 and β-catenin staining both showed an overall increase in staining intensity of the reactive ductules. Based on the suggestion that Wnt is merely involved in proliferation while notch in differentiation, this suggests that under these circumstances there is an increased demand for cholangiocytes and hepatocytes and therefore both Notch-1 and β-catenin show increased staining. This suits earlier staining results of LDH tissue in which increased staining of β-catenin and Notch-1 was seen as well [15].
In PPVH, a disease in which extended fibrosis can be found in the portal area without an inflammatory component, little, moderate and high amounts of reactive ductules were seen. Since the exact pathophysiology of PPVH is still not clear, the variation in reactive ductules amounts could be due to (not yet known) variation in severity or expression of PPVH. Notch-1 staining showed only little positivity in one slide, in area’s where large amounts of reactive ductules were found as well. Other slides with increased numbers of reactive ductules didn’t show Notch-1 positivity. This suggests that in some forms of PPVH, LPC’s differentiate into cholangiocytes and in other forms they don’t. The exact reason for this is not yet clear. The β-catenin staining of PPVH tissue showed increased positivity of reactive ductules in all three slides in which the amount of reactive ductules was increased. In the two slides in which no increase of reactive ductules was seen, only little β-catenin positivity was seen. This shows that in certain forms of PPVH, LPC’s proliferate and differentiate into hepatocytes, influenced by Wnt. 






Since negative controls for Notch-1 as well as for β-catenin showed positive staining, suggestions and conclusions based on the stainings can’t be made with certainty. Reason for the negative control slides to be positive could be a lack of specificity of the antibody, although the rest of the results don’t seem to support this option because of the staining intention variation observed in other slides. Another reason could be that errors have occurred during the processing of the slides. We weren’t able to identify the exact reason for the negative control slides to be positive. In the future, staining results will hopefully be accompanied by negative controls, making results more reliable.
Taken together, the obtained data provide insight in the role of signaling pathways Notch-1 and Wnt in the activation of LPC’s in different liver diseases in the dog. Although the precise role of these signaling pathways has not been demonstrated unequivocally in the current report, results form a suitable base for future research.

Current research
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Paraffin-embedded liver tissue, Notch 1 protocol- and results table

COUPE	ANTIGEN RETRIEVAL	(BOILING) TIME	H2O2 BLOCK	WASH	SERUM BLOCK	ANTIBODY	FINDINGS
N50	None	-	0.35%	PBS(T)	10% normal goat	1:50	Negative
N150	None	-	0.35%	PBS(T)	10% normal goat	1:150	Negative
C50	Citrate pH 6,0	15 min	0.35%	PBS(T)	10% normal goat	1:50	Little bile duct staining No membrane staining
C150	Citrate pH 6,0	15 min	0.35%	PBS(T)	10% normal goat	1:150	Negative
P50	Pepsin 0,4%	15 min	0.35%	PBS(T)	10% normal goat	1:50	Negative
P150	Pepsin 0,4%	15 min	0.35%	PBS(T)	10% normal goat	1:150	Negative
P25	Proteinase K	15 min	0.35%	PBS(T)	10% normal goat	1:25	Negative
P500	Proteinase K	15 min	0.35%	PBS(T)	10% normal goat	1:500	Negative
C25	Citrate pH 6,0	30 min	0.35%	PBS(T)	10% normal goat	1:25	Negative
C500	Citrate pH 6,0	30 min	0.35%	PBS(T)	10% normal goat	1:500	Negative
M25	MiliQ	30 min	0.35%	PBS(T)	10% normal goat	1:25	Little bile duct staining No membrane staining No background staining
M500	MiliQ	30 min	0.35%	PBS(T)	10% normal goat	1:500	Negative
E25A	TRIS EDTA pH 9,0	30 min	0.35%	PBS(T)	10% normal goat	1:25	Little bile duct staining Little/no membrane staining
E500	TRIS EDTA pH 9,0	30 min	0.35%	PBS(T)	10% normal goat	1:500	Negative
--	Trypsin 0,4%	15 min	0.35%	PBS(T)	10% normal goat	1:25	Slide let loose
--	Trypsin 0,4%	15 min	0.35%	PBS(T)	10% normal goat	1:50	Slide let loose
E25B	TRIS EDTA pH 10,0	30 min	0.35%	PBS(T)	10% normal goat	1:25	Bile duct staining Little membrane staining High background staining Periportal & -venous field staining
LDH;	TRIS EDTA pH 9,0	30 min	0.35%	PBS(T)	10% normal goat	1:50	Bile duct staining Little membrane staining High background staining
AUS50A	AUS	3 min	0.35%	PBS(T)	10% normal goat	1:50	Negative
E30T50	TRIS EDTA pH 10,0	30 min	0.35%	(T)TBS	10% normal goat	1:50	High background staining No membrane staining Periportal & -venous field staining
E10T50	TRIS EDTA pH 10,0	10 min	0.35%	(T)TBS	10% normal goat	1:50	High background staining No membrane staining Periportal & -venous field staining
E30T100	TRIS EDTA pH 10,0	30 min	0.35%	(T)TBS	10% normal goat	1:100	High background staining No membrane staining Periportal & -venous field staining
E10T100	TRIS EDTA pH 10,0	10 min	0.35%	(T)TBS	10% normal goat	1:100	High background staining No  membrane staining Periportal & -venous field staining
T10 50	EGTA pH 10,0	10 min	0.35%	PBS(T)	10% normal goat	1:50	High background staining No membrane staining Periportal & -venous field staining
T30 50	EGTA pH 10,0	30 min	0.35%	PBS(T)	10% normal goat	1:50	High background staining No membrane staining Periportal & -venous field staining
ABGS 10 50	TRIS EDTA pH 10,0	10 min	0.35%	PBS(T)	10% normal goat	In 10% goat serum 1:25	Less background staining No membrane staining Periportal & -venous field staining
ABGS 30 50	TRIS EDTA pH 10,0	30 min	0.35%	PBS(T)	10% normal goat	In 10% goat serum 1:25	Negative
SH2O2 10 50	TRIS EDTA pH 10,0	10 min	standard	PBS(T)	10% normal goat	1:50	Negative
SH2O2 30 50	TRIS EDTA pH 10,0	30 min	standard	PBS(T)	10% normal goat	1:50	High background staining No membrane staining
GS10 50	TRIS EDTA pH 10,0	10 min	0.35%	PBS(T)	20% normal goat	1:50	High background staining No membrane staining
GS30 50	TRIS EDTA pH 10,0	30 min	0.35%	PBS(T)	20% normal goat	1:50	High background staining No membrane staining
30 GS 50	TRIS EDTA pH 10,0	30 min	0.35%	PBS(T)	30% normal goat	1:50	Negative
AB 20GS50	TRIS EDTA pH 10,0	30 min	0.35%	PBS(T)	10% normal goat	In 20% goat serum 1:50	High background staining No membrane staining Periportal & -venous field staining
BSA 50	TRIS EDTA pH 10,0	30 min	0.35%	PBS(T)	3% BSA	1:50	Negative
SH2O2 50	TRIS EDTA pH 10,0	30 min	standard	PBS(T)	30% normal goat	1:50	Negative
LDH 50	TRIS EDTA pH 10,0	30 min	standard	PBS(T)	30% normal goat	In 10% goat serum 1:50	Little background staining No membrane staining
GGS 50	TRIS EDTA pH 10,0	30 min	standard	PBS(T)	10% normal goat	In 10% goat serum 1:50	High background staining No membrane staining
BSAB1 50	TRIS EDTA pH 10,0	30 min	standard	PBS(T)	BSA 1%	In 1% BSA 1:50	High background staining No membrane staining
BSAB2 50	TRIS EDTA pH 10,0	30 min	standard	PBS(T)	BSA 0,05%	In 0,01% BSA 1:50	High background staining No membrane staining
T30A	TRIS EDTA pH 10,0	30 min	standard	PBS(T)	15% normal goat	In 15% goat serum 1:50 1night	High background staining No membrane staining 
T20A	TRIS EDTA pH 10,0	20 min	standard	PBS(T)	15% normal goat	In 15% goat serum 1:50 1night	Less background staining No membrane staining 
T30B	TRIS EDTA pH 10,0	30 min	standard	PBS(T)	15% normal goat	In 15% goat serum 1:50 2nights	High background staining No membrane staining 
T20B	TRIS EDTA pH 10,0	20 min	standard	PBS(T)	15% normal goat	In 15% goat serum 1:50 2nights	High background staining No membrane staining 
T30C	TRIS EDTA pH 10,0	30 min	standard	PBS(T)	15% normal goat	In 15% goat serum 1:50 day	High background staining No membrane staining 
T20C	TRIS EDTA pH 10,0	20 min	standard	PBS(T)	15% normal goat	In 15% goat serum 1:50 day	High background staining No membrane staining 
TW 35 A	TRIS EDTA pH 10,0	30 min waterbath	0.35% After A.R.	PBS(T)	10% normal goat	1:25	High background staining No membrane staining
TW S A	TRIS EDTA pH 10,0	30 min waterbath	StandardAfter A.R.	PBS(T)	10% normal goat	1:25	High background staining No membrane staining
TM 35 A	TRIS EDTA pH 10,0	30 min microwave	0.35% After A.R.	PBS(T)	10% normal goat	1:25	High background staining No membrane staining
TM S A	TRIS EDTA pH 10,0	30 min microwave	StandardAfter A.R.	PBS(T)	10% normal goat	1:25	High background staining No membrane staining
TW 35 B	TRIS EDTA pH 10,0	30 min waterbath	0.35% Before A.R.	PBS(T)	10% normal goat	1:25	High background staining No membrane staining
TW S B	TRIS EDTA pH 10,0	30 min waterbath	StandardBefore A.R.	PBS(T)	10% normal goat	1:25	High background staining No membrane staining
TM 35 B	TRIS EDTA pH 10,0	30 min microwave	0.35% Before A.R.	PBS(T)	10% normal goat	1:25	High background staining No membrane staining




































Paraffin-embedded liver tissue: β-catenin protocol- and results table

COUPE	ANTIGEN RETRIEVAL	BOILING TIME	H2O2 BLOCK	WASH	SERUM BLOCK	ANTIBODY	FINDINGS
N50	None	3 min	0.35%	0.025% T TBS	3% BSA in  T TBS	1:50	Little background staining No membrane staining
C50	Sodium citrate pH 6.0	15 min	0.35%	0.025% T TBS	3% BSA in  T TBS	1:50	Little background staining Little membrane staining
AUS 50	A.U.S.	3 min	0.35%	0.025% T TBS	3% BSA in  T TBS	1:50	Little background staining Little membrane staining
AUS 100	A.U.S.	3 min	0.35%	0.025% T TBS	3% BSA in  T TBS	1:100	Less background staining and membrane staining than AUS 50
AUS SG50	A.U.S.	3 min	0.35%	0.025% T TBS	10% normal goat	1:50	A lot of background staining especially cytoplasmatic No membrane staining
AUS SG100	A.U.S.	3 min	0.35%	0.025% T TBS	10% normal goat	1:100	Less backgroundstaining than AUS SG50 no specific membrane staining
POS BSA50	A.U.S.	3 min	0.35%	0.025% T TBS	3% BSA in  T TBS	1:50	Merg; membrane staining Cortex; nucleusstaining
POS SG50	A.U.S.	3 min	0.35%	0.025% T TBS	10% normal goat	1:50	Negative
H2O2 50	A.U.S.	3 min	standard	0.025% T TBS	3% BSA in  T TBS	1:50	slide let loose
OI 50	A.U.S.	3 min	0.35%	0.025% T TBS	3% BSA in  T TBS	1:50 overnight	slide let loose
OI 50	A.U.S.	3 min	0.35%	0.025% T TBS	3% BSA in  T TBS	1:50 overnight	Little background staining Little membrane staining
H2O2 50	A.U.S.	3 min	standard	0.025% T TBS	3% BSA in  T TBS	1:50	Reasonable background staining Little membrane staining
CB 50	Citrate buffer pH = 6,0	20 min	0.35%	0.025% T TBS	3% BSA in  T TBS	1:50	Little background staining Little membrane staining
LDH 50	A.U.S.	3 min	0.35%	0.025% T TBS	3% BSA in  T TBS	1:50	Negative
LDH 1	A.U.S.	3 min	standard	0.025% T TBS	3% BSA in  T TBS	1:50	Negative
ECH 1	A.U.S.	3 min	standard	0.025% T TBS	3% BSA in  T TBS	1:50	 Little background staining Little membrane staining
AH/FH 1	A.U.S.	3 min	standard	0.025% T TBS	3% BSA in  T TBS	1:50	 Little background staining Little membrane staining
PPVH 1	A.U.S.	3 min	standard	0.025% T TBS	3% BSA in  T TBS	1:50	 Little background staining Little membrane staining
CH/CI 1	A.U.S.	3 min	standard	0.025% T TBS	3% BSA in  T TBS	1:50	 Little background staining Little membrane staining
















































stainingprotocol for Notch 1, paraffin embedded liver tissue, Rabbit anti-bodies: Sc-6014 R

-Deparaffine serie: 
-Xyleen 1, Xyleen 2							2 x 5 min.
-Alc96%, Alc80%, Alc70%, Alc60%, Alc30%				5 x 5 min.	
-PBS									5 min.

-Rinse with Kimwipe cloth, circle slide with PAP pencil

-Various antigen retrievals							variable lengths

-H2O2 block;	-Standard H2O2 DAKO or 0,35% H2O2				5/15 min.

-Rinse in PBST									3 x 3 min.

-Treat with normal goat serum (1:10-1:30) in PBS in a humid chamber		30 min.

-Incubate with;	-A; PBS (negative control)
						
		-B; 6014-R rabbit (primary) antibody, dilution;		1:25- 1:500
 (dilution range 1:50-1:500, Santa Cruz Biotechnology, Stored at 4 °C)												Overnight
------------------------------------------------------------------------------------------------------------
-Rinse in PBST									3 x 5 min.

-Incubate with Envision goat-anti-rabbit (secondary) antibody K4003		30 min. RT

-Rinse in PBS									3 x 5 min.

-Incubate with freshly made DAB, watch colour development; note time!	-- min.

-Rinse in running tap water							5 min.

-Counter stain with haematoxylin, 1:1 PBS					10 sec.

-Rinse in running tap water							5 min.

-Cover slide with Faramount aqueous mounting medium















Stainingprotocol for Wnt (β-catenin), paraffin embedded liver tissue,  AB 2982

-Deparaffine serie: 
-Xyleen 1, Xyleen 2								2 x 5 min.





 -Cooling down										variable lengths





-Dry slides and take off as much liquid as you can 

-Draw circles round coupe with ImmEdgde pen 
-200 ul, or as much as you need to cover the coupes completely (humidity chamber),
with diluted 1st antibody;	-1:50 (20 μg/ml in 1% BSA, 0,025% Triton X-100 in TBS)
			
-Keep container at room temp								overnight
---------------------------------------------------------------------------------------------------------------------------
- Rinse											2 x 5 min.

-Dry slides and take off as much liquid as you can

-H2O2 block;	-Standard H2O2 DAKO or 0,35% H2O2					5/15 min.

-2nd antibody at room temperature (Envision anti-Rabbit K4003)			30 min.

-Rinse											2 x 5 min.

-Dry slides and take off as much liquid as you can 

-Incubate each slide with 200 µl DAB-solution						15 min. RT

-Put the sections in a container with milliQ water

-Dry slides and take off as much liquid as you can

-Cover sections for a few seconds with some drops of hematoxylin

-Flush sections with tap water								10 min.

Add enough drops aqueous mounting medium on each section and mount a cover glass 











Stainingprotocol for Envision method for anti CK7 Frozen sections

1.	Place slide box in aluminium foil from -70 at RT			20 min.
2.	Remove slides from slidebox and dry at air				10 min.	
3.	Rinse in PBS/Tween							3 min.	
4.	Block endogenous peroxidase activity with DAKO standard H2O2	30 min
5.	Rinse in PBS/Tween							3x3 min
6.	Treat with Normal Goat Serum 1:10 in PBS.				30 min
7.	Incubate 	a) with Mouse anti CK7 1:50	 (K4001)		30 min RT
b) with PBS (negative control)
8.	Rinse in PBS/Tween							3x5 min
9.	Incubate with Envision Goat anti mouse				30 min RT
10.	Rinse in PBS (without Tween) 						3x5 min
11.	Prepare DAB
12.	Incubate in freshly made DAB						5 min.
13.	Discard in jerrycan IV
Rinse 1x in tapwater in fumehood, discard in jerrycan IV
           Rinse in running tapwater						5 min
     16. Counter stain with haematoxylin					30 sec
     20. Rinse in running tapwater						10 min
     21. Dehydrate in 1x alc 60%- 1x alc 70% 2x alc 96%- 2x xylene		3 min. each step





























Protocol for Envision method on Frozen sections; Notch1

1.	Place slide box in aluminium foil from -70 at RT			20 min.
2.	Remove slides from slidebox and dry at air				10 min.	
3.	Rinse in TBS-0.025% Triton						3 min.	
4.	Block endogenous peroxidase activity with DAKO standard H2O2 	5 min
5.	Rinse in TBS-0.025% Triton						3x3 min
6.	Treat with Normal Goat Serum 1:10 in TBS.				30 min
7.	Incubate 	A) Notch1; 6014-R rabbit 1:50 in TBS-0.025% Triton Overnight
B) rabbit serum 1:3000 in TBS-0.025% Triton 
(negative control)					Overnight
8.	Rinse in TBS-0.025% Triton					          3x5 min
9.	Incubate with Envision Goat anti rabbit K4003				45 min RT
10.	Rinse in TBS (without 0.025% Triton) 					3x5 min
11.	Prepare DAB
12.	Incubate in freshly made DAB						5 min.
13.	Discard in jerrycan IV
Rinse 1x in tapwater in fumehood, discard in jerrycan IV
           Rinse in running tapwater						5 min
     16. Counter stain with haematoxylin 1:1 in TBS				10 sec
     17. Rinse in running tapwater						10 min
     18. Dehydrate in 1x alc 60%- 1x alc 70% 2x alc 96%- 2x xylene		3 min. each step





















Protocol for Envision method on Frozen sections; β-catenin

1.	Place slide box in aluminium foil from -70 at RT			20 min.
2.	Remove slides from slidebox and dry at air				10 min.	
3.	Rinse in TBS-0.025% Triton						3 min.	
4.	Block endogenous peroxidase activity with DAKO standard H2O2 	5 min
5.	Rinse in TBS-0.025% Triton						3x3 min
6.	Treat with Normal Goat Serum 1:10 in TBS.				30 min
7.	Incubate 	A) β-catenin; AB 2982 1:200 in TBS-0.025% Triton	Overnight
B) rabbit serum 1:3000 in TBS-0.025% Triton 
(negative control)					Overnight
8.	Rinse in TBS-0.025% Triton						3x5 min
9.	Incubate with Envision Goat anti rabbit K4003				30 min RT
10.	Rinse in TBS (without Triton) 						3x5 min
11.	Prepare DAB
12.	Incubate in freshly made DAB						5 min.
13.	Discard in jerrycan IV
Rinse 1x in tapwater in fumehood, discard in jerrycan IV
           Rinse in running tapwater						5 min
     16. Counter stain with haematoxylin 1:1 in TBS				10 sec
     17. Rinse in running tapwater						10 min
     18. Dehydrate in 1x alc 60%- 1x alc 70% 2x alc 96%- 2x xylene		3 min. each step

































Fig. 3; Notch signalling pathway [Wikipedia]


    Fig. 5; Wnt signalling pathway [11]

      Fig. 7; Immunohistochemical binding of specific antibodies [10]
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